Navigation Links
LSUHSC research adds new info to improve pediatric dental sedation
Date:7/8/2013

New Orleans, LA -- Research led by Priyanshi Ritwik, DDS, MS, LSUHSC Associate Professor of Pediatric Dentistry at LSU Health Sciences Center New Orleans, reports important findings about side effects and how long they linger after discharge of common oral drugs used to sedate some children during dental procedures. The results of the study, published in the current issue of Anesthesia Progress, provide pediatric dentists and parents with new information on this previously little-investigated aspect of children's dental health care.

The prospective study, conducted at the LSU Health Sciences Center New Orleans School of Dentistry, compared the incidence and duration of side effects of meperidine and hydroxyzine versus midazolam alone at 8 and 24 hours after sedation. The researchers found that while most adverse reactions occurred within eight hours, some continued up to 24 hours. They noted that children sedated with meperidine and hydroxyzine experienced vomiting, but not those sedated with midazolam. Prolonged sleep at home was significantly higher in the children sedated with meperidine and hydroxyzine. Irritability was more common in the midazolam group in the first eight hours, declining thereafter, while the number of irritable children in the meperidine and hydroxyzine group increased in the 8- to 24-hour period. They also report that 50% of the children in both groups slept in the car on the way home. This is a potential risk for airway obstruction because while sleeping in a car seat, the child's head can tilt down to the chest. It has been found that children and infants sleeping in car safety seats have a significantly lower oxygen saturation. The research team recommends that parents bring another adult along to monitor and reposition the child's head if necessary on the drive home.

"It is critical to know the effects of these medications beyond the time spent by the child in the dental office, so that parents can be appropriately cautioned about the expected effects and how to distinguish them from any potential emergencies such as airway obstruction," says Dr. Ritwik.

The team also recommends that parents be educated about which medications can safely be used to manage postoperative pain and fever as well as how to use them correctly. Additionally since some children do not want to eat in the first eight hours after sedation, they advise that parents be informed to anticipate this and encouraged to support their child to take liquids to maintain hydration.

Other members of the LSUHSC research team included Linda T. Cao, DDS, and Robert J. Musselman, DDS, MSD, along with Ronald Curran, DDS. The researchers note that this is a small, preliminary study and that further research is needed. In the meantime, however, this study yields new information to improve the safety and comfort for children and their parents following dental care.


'/>"/>

Contact: Leslie Capo
lcapo@lsuhsc.edu
504-568-4806
Louisiana State University Health Sciences Center
Source:Eurekalert

Related medicine news :

1. LSUHSC research finds HPV-related head & neck cancers rising, highest in middle-aged white men
2. LSUHSCs Tilton awarded prestigious Hower Award
3. LSUHSC research finding keys to future obesity & related diseases
4. LSUHSC research provides new drug target for Her-2 related breast cancer
5. LSUHSC research discoveries shed light on common STI
6. LSUHSC research reveals Rx target for HPV, Hep C and related cancers
7. 8th edition of LSUHSC facultys textbook published
8. LSUHSC paper judged best of the year
9. LSUHSCs Hollier one of few ever awarded coveted national lectureship
10. UCLA Brain Injury Research Center gets NCAA funding for research on sports concussions
11. NIH awards $20 million over 5 years to train next generation of global health researchers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... , ... February 23, 2017 , ... ... thought leadership , media relations, content marketing, social media management, corporate communications, SEO ... already in the state and in nearby New Hampshire, Massachusetts and Canada, Rosica ...
(Date:2/23/2017)... ... February 23, 2017 , ... Pink Pig Publishing LLC announces ... and explore the world from different perspectives. By providing a place for people ... understanding, increase empathy, and find greater happiness. , "Our approach to structuring ...
(Date:2/23/2017)... ... 23, 2017 , ... The Center for Autism and Related ... Autism Research and Treatment (RI-CART) and Cinemaworld to present Sensory Friendly Films. The ... see films in an environment that accommodates their unique needs. , Launched in ...
(Date:2/23/2017)... ... February 23, 2017 , ... Curemark, LLC announced today that ... of CM-AT in children aged 3-8 with Autism, is now enrolling at three new ... children across the United States. , “There are currently no approved drugs that ...
(Date:2/22/2017)... York (PRWEB) , ... February 22, 2017 , ... ... entrance and lobby of a new healthcare contact center in Georgia, PENETRON Specialty ... One of the nation’s largest healthcare systems recently invested $51 million to purchase ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... Feb. 23, 2017   SeraCare Life Sciences ... in vitro diagnostics manufacturers and clinical laboratories, is ... Implementation of NGS-Based Tests" to be hosted by ... at 11am Eastern Standard Time (US). ... the need for improved performance and global standardization ...
(Date:2/23/2017)... DIEGO , Feb. 23, 2017 ... a clinical-stage oncology drug development company, announces that ... and Drug Administration (FDA) authorizing the initiation a ... therapeutic treatment for pancreatic cancer. MVT-1075 ( 177 ... radioimmunotherapy (RIT). MabVax plans to initiate the phase ...
(Date:2/23/2017)... This report analyzes analyzes the worldwide markets for Wound Debridement Products ... the US, Canada , Japan ... , Latin America , and Rest ... period 2015 through 2022. Also, a six-year historic analysis is ... from primary and secondary research. Company profiles are primarily based ...
Breaking Medicine Technology: